Francisella tularensis Real-time PCR assay
Centers for Disease Control and Prevention · K252072
FDA-authorized Predetermined Change Control Plan
- Company
- Centers for Disease Control and Prevention
- 510(k)/De Novo #
- K252072
- Decision date
- 2025-09-30
- Panel
- Immunology
- Pathway
- 510(k)
- Category
- Non-AI
- PCCP type
- Compatibility expansion
- Monitoring commitment
- Not stated
What this PCCP covers. Permits compatibility expansion to additional hardware
Other PCCPs from Centers for Disease Control and Prevention
- K260812Francisella tularensis Real-time PCR AssayCenters for Disease Control and Prevention2026-03-30Non-AIUnknown
- K243274CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel: Influenza A/B Typing Kit (VER 2); Influenza A SubTyping Kit (VER 4); Influenza B Genotyping Kit (VER 1.1 and 2); and Influenza A/H5 Subtyping Kit (VER 4)Centers for Disease Control and Prevention2025-07-11Non-AII/O expansion
Other Immunology PCCPs
Want the monitoring teardown?
We read the PCCP for Francisella tularensis Real-time PCR assay, then map the post-market monitoring that its modification protocol requires, including the deployment-period evidence most teams can't reconstruct at modification time. Sentir is the independent system of record that produces it.
Book a callSource: U.S. FDA public records (openFDA 510(k)/De Novo databases and accessdata.fda.gov). PCCP type and category are editorial classifications based on public documents, not official FDA designations.
This page is a factual summary of public FDA records. Sentir Health is not affiliated with or endorsed by the named companies or the U.S. Food and Drug Administration. Spot an error? Request a correction.